206 related articles for article (PubMed ID: 11470254)
1. Inhibitors of arachidonic acid metabolism potentiate tumour necrosis factor-alpha-induced apoptosis in HL-60 cells.
Vondrácek J; Stika J; Soucek K; Minksová K; Bláha L; Hofmanová J; Kozubík A
Eur J Pharmacol; 2001 Jul; 424(1):1-11. PubMed ID: 11470254
[TBL] [Abstract][Full Text] [Related]
2. PPARgamma ligands induce prostaglandin production in vascular smooth muscle cells: indomethacin acts as a peroxisome proliferator-activated receptor-gamma antagonist.
Bishop-Bailey D; Warner TD
FASEB J; 2003 Oct; 17(13):1925-7. PubMed ID: 12897060
[TBL] [Abstract][Full Text] [Related]
3. The effects of TNF-alpha and inhibitors of arachidonic acid metabolism on human colon HT-29 cells depend on differentiation status.
Kovaríková M; Hofmanová J; Soucek K; Kozubík A
Differentiation; 2004 Feb; 72(1):23-31. PubMed ID: 15008823
[TBL] [Abstract][Full Text] [Related]
4. Arachidonic acid activates Jun N-terminal kinase in vascular smooth muscle cells.
Madamanchi NR; Bukoski RD; Runge MS; Rao GN
Oncogene; 1998 Jan; 16(3):417-22. PubMed ID: 9467967
[TBL] [Abstract][Full Text] [Related]
5. Regulation of the cellular expression of secretory and cytosolic phospholipases A2, and cyclooxygenase-2 by peptide growth factors.
Pruzanski W; Stefanski E; Vadas P; Kennedy BP; van den Bosch H
Biochim Biophys Acta; 1998 May; 1403(1):47-56. PubMed ID: 9622592
[TBL] [Abstract][Full Text] [Related]
6. Inhibitors of lipoxygenase metabolism exert synergistic effects with retinoic acid on differentiation of human leukemia HL-60 cells.
Hofmanová J; Kozubík A; Dusek L; Pacherník J
Eur J Pharmacol; 1998 Jun; 350(2-3):273-84. PubMed ID: 9696418
[TBL] [Abstract][Full Text] [Related]
7. Signaling mechanisms involved in the activation of arachidonic acid metabolism in human astrocytoma cells by tumor necrosis factor-alpha: phosphorylation of cytosolic phospholipase A2 and transactivation of cyclooxygenase-2.
Hernández M; Bayón Y; Sánchez Crespo M; Nieto ML
J Neurochem; 1999 Oct; 73(4):1641-9. PubMed ID: 10501211
[TBL] [Abstract][Full Text] [Related]
8. Absence of modulation of monokine production via endogenous cyclooxygenase or 5-lipoxygenase metabolites: MK-886 (3-[1-(4-chlorobenzyl)-3-t-butyl-thio-5-isopropylindol-2-yl]-2,2- dimethylpropanoic acid), indomethacin, or arachidonate fail to alter immunoreactive interleukin-1 beta, or TNF-alpha production by human monocytes in vitro.
Hoffman T; Lee YL; Lizzio EF; Tripathi AK; Jessop JJ; Taplits M; Abrahamsen TG; Carter CS; Puri J
Clin Immunol Immunopathol; 1991 Mar; 58(3):399-408. PubMed ID: 1900463
[TBL] [Abstract][Full Text] [Related]
9. 24R,25-(OH)(2)D(3) mediates its membrane receptor-dependent effects on protein kinase C and alkaline phosphatase via phospholipase A(2) and cyclooxygenase-1 but not cyclooxygenase-2 in growth plate chondrocytes.
Schwartz Z; Sylvia VL; Del Toro F; Hardin RR; Dean DD; Boyan BD
J Cell Physiol; 2000 Mar; 182(3):390-401. PubMed ID: 10653606
[TBL] [Abstract][Full Text] [Related]
10. Phospholipase A2 activation and autoinduction of tumor necrosis factor gene expression by tumor necrosis factor.
Spriggs DR; Sherman ML; Imamura K; Mohri M; Rodriguez C; Robbins G; Kufe DW
Cancer Res; 1990 Nov; 50(22):7101-7. PubMed ID: 2121330
[TBL] [Abstract][Full Text] [Related]
11. Arachidonic acid mediates interferon-gamma-induced sphingomyelin hydrolysis and monocytic marker expression in HL-60 cell line.
Visnjić D; Batinić D; Banfić H
Blood; 1997 Jan; 89(1):81-91. PubMed ID: 8978280
[TBL] [Abstract][Full Text] [Related]
12. Effects of 1alpha,25-(OH)(2)D(3) on rat growth zone chondrocytes are mediated via cyclooxygenase-1 and phospholipase A(2).
Sylvia VL; Del Toro F; Dean DD; Hardin RR; Schwartz Z; Boyan BD
J Cell Biochem Suppl; 2001; Suppl 36():32-45. PubMed ID: 11455568
[TBL] [Abstract][Full Text] [Related]
13. Expression of 15-lipoxygenase by human colorectal carcinoma Caco-2 cells during apoptosis and cell differentiation.
Kamitani H; Geller M; Eling T
J Biol Chem; 1998 Aug; 273(34):21569-77. PubMed ID: 9705287
[TBL] [Abstract][Full Text] [Related]
14. Cyclooxygenase-2 (COX-2) inhibitors sensitize tumor cells specifically to death receptor-induced apoptosis independently of COX-2 inhibition.
Totzke G; Schulze-Osthoff K; Jänicke RU
Oncogene; 2003 Sep; 22(39):8021-30. PubMed ID: 12970750
[TBL] [Abstract][Full Text] [Related]
15. Phospholipase A2 inhibitors and leukotriene synthesis inhibitors block TNF-induced NF-kappaB activation.
van Puijenbroek AA; Wissink S; van der Saag PT; Peppelenbosch MP
Cytokine; 1999 Feb; 11(2):104-10. PubMed ID: 10089130
[TBL] [Abstract][Full Text] [Related]
16. Enhancement of stress-induced synthesis of hsp27 and alpha B crystallin by modulators of the arachidonic acid cascade.
Ito H; Hasegawa K; Inaguma Y; Kozawa O; Kato K
J Cell Physiol; 1996 Feb; 166(2):332-9. PubMed ID: 8591993
[TBL] [Abstract][Full Text] [Related]
17. Inhibitors of the arachidonic acid pathway and peroxisome proliferator-activated receptor ligands have superadditive effects on lung cancer growth inhibition.
Avis I; Martínez A; Tauler J; Zudaire E; Mayburd A; Abu-Ghazaleh R; Ondrey F; Mulshine JL
Cancer Res; 2005 May; 65(10):4181-90. PubMed ID: 15899809
[TBL] [Abstract][Full Text] [Related]
18. Apo2L/TRAIL differentially modulates the apoptotic effects of sulindac and a COX-2 selective non-steroidal anti-inflammatory agent in Bax-deficient cells.
He Q; Luo X; Huang Y; Sheikh MS
Oncogene; 2002 Sep; 21(39):6032-40. PubMed ID: 12203115
[TBL] [Abstract][Full Text] [Related]
19. Modulation of glutamate and aspartate release from slices of hippocampal area CA1 by inhibitors of arachidonic acid metabolism.
Peterson CL; Thompson MA; Martin D; Nadler JV
J Neurochem; 1995 Mar; 64(3):1152-60. PubMed ID: 7861146
[TBL] [Abstract][Full Text] [Related]
20. Biochemical and pharmacological profile of a tetrasubstituted furanone as a highly selective COX-2 inhibitor.
Riendeau D; Percival MD; Boyce S; Brideau C; Charleson S; Cromlish W; Ethier D; Evans J; Falgueyret JP; Ford-Hutchinson AW; Gordon R; Greig G; Gresser M; Guay J; Kargman S; Léger S; Mancini JA; O'Neill G; Ouellet M; Rodger IW; Thérien M; Wang Z; Webb JK; Wong E; Chan CC
Br J Pharmacol; 1997 May; 121(1):105-17. PubMed ID: 9146894
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
